222 related items for PubMed ID: 28882100
1. Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety.
Yu X, Ruan L, Qu Z, Cui Z, Zhang Y, Wang X, Meng L, Liu X, Wang F, Zhang Y, Liu G, Yang L.
Ren Fail; 2017 Nov; 39(1):688-697. PubMed ID: 28882100
[Abstract] [Full Text] [Related]
2. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[Abstract] [Full Text] [Related]
3. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[Abstract] [Full Text] [Related]
4. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
Li J, Zhang YM, Qu Z, Zhao MH, Liu G.
Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
[Abstract] [Full Text] [Related]
5. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C, Li H, Wen YB, Li JN, Lin WF, Cai JF, Duan L, Li Y, Li XM, Li XW.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):544-551. PubMed ID: 28877834
[Abstract] [Full Text] [Related]
6. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY, Chinese Nephropathy Membranous Study Group.
Am J Med Sci; 2010 Mar 20; 339(3):233-8. PubMed ID: 20220333
[Abstract] [Full Text] [Related]
7. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, Li XM, Li XW.
Chin Med J (Engl); 2011 Nov 20; 124(21):3490-4. PubMed ID: 22340164
[Abstract] [Full Text] [Related]
8. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Hassan K, Kristal B.
Minerva Urol Nefrol; 2016 Jun 20; 68(3):293-301. PubMed ID: 25645342
[Abstract] [Full Text] [Related]
9. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P, Koutroulia E, Sotsiou F, Vlachojannis JG, Goumenos DS.
Nephrology (Carlton); 2010 Dec 20; 15(8):762-7. PubMed ID: 21175962
[Abstract] [Full Text] [Related]
10. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Matsumoto H, Nagaoka Y, Okada T, Wada T, Gondo A, Esaki S, Hayashi A, Miyaoka Y, Nakao T.
Intern Med; 2011 Dec 20; 50(18):1905-10. PubMed ID: 21921367
[Abstract] [Full Text] [Related]
11. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
Ren Fail; 2017 Nov 20; 39(1):512-518. PubMed ID: 28562168
[Abstract] [Full Text] [Related]
12. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
Ren Fail; 2013 Aug 20; 35(7):936-41. PubMed ID: 23815417
[Abstract] [Full Text] [Related]
13. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z, Cai M, Dong B, Yan Y, Wang Y, Li X, Shao C, Zuo L.
BMC Nephrol; 2021 Apr 22; 22(1):148. PubMed ID: 33888083
[Abstract] [Full Text] [Related]
14. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?
Goumenos DS.
Expert Opin Pharmacother; 2008 Jul 22; 9(10):1695-704. PubMed ID: 18570603
[Abstract] [Full Text] [Related]
15. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC, Mentor Consortium group.
Nephron; 2015 Jul 22; 130(3):159-68. PubMed ID: 26087670
[Abstract] [Full Text] [Related]
16. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W, Liu Z, Shen S, Li S, Yao X, Chen H, Li L.
Chin Med J (Engl); 2003 Dec 22; 116(12):1827-30. PubMed ID: 14687467
[Abstract] [Full Text] [Related]
17. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov 22; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
18. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 Nov 22; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
19. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL, North America Nephrotic Syndrome Study Group.
Kidney Int; 2001 Apr 22; 59(4):1484-90. PubMed ID: 11260412
[Abstract] [Full Text] [Related]
20. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W, Pei H, Li S, Fu S, Tian L.
Zhonghua Nei Ke Za Zhi; 2016 Mar 22; 55(3):181-5. PubMed ID: 26926368
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
